2024年6月：慧晓律师成功为23家跨国及国内知名药企提供《中国法下同情用药合规监管要点分享》培训June 2024 : HUI XIAO Lawyer Successfully Provided Training on Key Regulatory Compliance Points for the Use of Compassionate Drug under China Law
2024年6月27日，上海慧晓律师事务所主任和中国、美国执业律师谢晓云女士应邀通过安拓掌上课堂平台成功举办首次网络直播课和主讲《中国法下同情用药合规监管要点分享》（含问答环节），共计23家跨国药企和国内知名药企参加此网络直播课，包括：
On 27 June 2024, Ms. Ellen Xie, Managing Director and Lawyer admitted in China and California (the United States) of Shanghai Hui Xiao Law Group was invited to provide and successfully completed the first webcast training on Key Regulatory Compliance Points for the Use of Compassionate Drug under China Law including Q & A session through EverLaw webcast platform with healthcare professionals from the following 23 leading multinational pharmaceutical corporations and domestic pharmaceutical companies attending the webcast training:
l 诺华Novartis；
l 赛诺菲Sanofi；
l 益普生Ipsen；
l 恒瑞医药Jiangsu Hengrui Medicine；
l 复宏汉霖Henlius Biotech；
l 武田Takeda；
l 诺和诺德Novo Nordisk；
l 华润China Resources；
l 健适Jianshi；
l 诺唯赞Novozan；
l 阿斯利康AstraZeneca；
l 费森尤斯卡比Fresenius；
l 舒万诺Solventum；
l 强生Johnson & Johnson；
l 先声药业Simcere；
l 拜耳Bayer；
l 再鼎Zaiding；
l 奥林巴斯Olympus；
l 森世海亚Senshi Haiya；
l 康乐保Kanglebao；
l 勃林格殷格翰Boehringer-Ingelheim；
l 百济神州Beigene；
l 赞邦 Zanbang
。
如你对此网络直播课有兴趣，可联系我们或登录安拓App观看此网络直播课的录播回放。
If you have interest in this webcast course, you can contact us or view the recording of this webcast course through EverLaw App.
